Circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis

Sema Misir, Sema Mısır, Ceylan Hepokur, Buğra Okşaşoğlu, Bugra Oksasoglu, Çağlar Yıldız, Caglar Yildiz, Ali Yanik, Ali Yanık, Yüksel Aliyazicioglu, Yüksel Aliyazıcıoğlu
Journal of gynecology obstetrics and human reproduction · 2021 · vol. 50(4) , pp. 102092 · doi:10.1016/j.jogoh.2021.102092 · PMID:33601073 · W3132707236
article OA: closed CC0 ⤵ 19 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the potential of circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis MicroRNAs Adult Biomarkers Biomarkers CA-125 Antigen CA-125 Antigen Endometriosis Endometriosis Female Humans MicroRNAs Real-Time Polymerase Chain Reaction ROC Curve Sensitivity and Specificity

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Cited by (19)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:49.034193+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK